Gate2Brain
  • Home
  • Company
    • Mission & vision
    • Awards & Recognitions
    • Seals & Product Designations
    • Supported by
  • About us
    • Founders
    • Team
    • Advisory board
    • Values
    • Our Story
  • Technology
    • Scientific Publications
  • Pipeline-Proof of Concept
  • Investors
  • ESG
  • News & Media
  • Contact
  • Menu Menu

Plug & Play Biotech Pitch

Events

We have been invited by Plug & Play to pitch Gate2Brain at their Biotech focused pitch session on January 19th, 2024 via Zoom Webinar. The session will run from 10am – 12:15pm. 

We will be pitching our project to a panel of 100+ VCs & Selected Corporate Partners which may provide both investment and BD opportunities.

Plug and Play is a global ecosystem for startups, VCs and Corporations.

January 15, 2024/by noticias
Tags: Biotech, pitch, plugandplay
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2024/01/Plug-Play-900-x-800-px.png 800 900 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2024-01-15 12:38:582024-01-15 12:40:24Plug & Play Biotech Pitch
You might also like
It’s Gate2Brain second anniversary!! 🎂 The creativity, work and dedication of Gate2Brain's team can only be matched with its desire to bring medicines beyond barriers.Gate2BrainGate2Brain second anniversary
G2B among the 6 finalist startups at the Trans-Atlantic Angel Conference
PaidhosGate2Brain wants to deliver drugs to the brain to combat intact barrier brain tumors, such as DIPG
Three University of Barcelona spin-offs led by women will receive funding as part of the Women TechEU pilot callFundació Bosch i GimperaThree University of Barcelona spin-offs receive funding from Women TechEU
Many drugs do not reach the brain and Gate2Brain technology helps to overcome that bottleneck
Gate2Brain among the 20 BioTech Startups to Watch in 2024
Sometimes drugs need a bigger push to be more effective and reach their final destination:ExpansionThe drug booster to the brain
Next Wednesday, February 16, @Gate2Brain will be in #Transfiere, European Forum for Science, Technology and Innovation to be held in Malaga. Our CEO, @Meritxell Teixidó, will participate as a speaker together with 16 other companies, at the #Boosting Zone for being one of the companies that have been awarded the #NEOTEC2021 program of the @CDTI, Centro para el Desarrollo Tecnológico Industrial. Boosting Zone is a space for promoting innovation and technology transfer from scientific-based companies.TransfiereGate2Brain in Transfiere – European Forum for Science, Technology & Innovation

CATEGORIES

  • Advisory Board
  • Events
  • Funding & Breakthroughs
  • Interviews
  • Media & Press
  • Media Coverage
  • News
  • Podcasts
  • Press releases
  • Research & Publications
  • Sin categoría
  • Video Content

Events

  • Gate2Brain Selected for the EU Business Hub Mission at World Health Expo Osaka 2026June 23, 2026 - 13:31
  • Gate2Brain to Participate in the Barcelona Deep Tech Summit 2025November 3, 2025 - 10:23
  • Gate2Brain at BioJapan 2025 — Enabling Innovative Brain Delivery SolutionsOctober 15, 2025 - 12:56
  • Gate2Brain turns 5!July 9, 2025 - 18:07
  • Bioengineering the Future of Drug Delivery workshop – PortoApril 8, 2025 - 10:03

SOCIAL

  • linkedin
  • youtube
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
The UB spin-off Gate2Brain wins the Senén Vilaró Prize for the development...Gloria García – Meet the Advisory Board
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}